FDA expands uses of Vyvanse to treat binge-eating disorder

The U.S. Food and Drug Administration today expanded the approved uses of Vyvanse (lisdexamfetamine dimesylate) to treat binge-eating disorder in adults. The drug is the first FDA-approved medication to treat this condition.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm432543.htm

Source: Food and Drug Administration - January 30, 2015 Category: American Health Source Type: news

More News: American Health | Binge Eating Disorder | Food and Drug Administration (FDA) | Vyvanse